scAAVengr Derived Intravitreal Vectors for Ophthalmic Gene Therapy
Time: 11:30 am
day: Conference Day One
Details:
- New data on Avista’s lead candidate capsids for intravitreal delivery
- AI/Machine Learning techniques to identify and optimize capsids
- Advancement towards clinical indications for Avista’s internal pipeline
Speakers:
